Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

Glioblastoma is a deadly brain cancer with limited treatment options. Targeting chondroitin sulfate proteoglycan 4 (CSPG4, best known as NG2) with the monoclonal antibody mAb9.2.27 and activated natural killer (NK) cells abrogated the tumor growth and prolonged the survival of glioblastoma-bearing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kmiecik, Justyna, Gras Navarro, Andrea, Poli, Aurelie, Planagumà, Jesús Planagumà, Zimmer, Jacques, Chekenya, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916357/
https://www.ncbi.nlm.nih.gov/pubmed/24575382
http://dx.doi.org/10.4161/onci.27185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916357/
https://www.ncbi.nlm.nih.gov/pubmed/24575382
http://dx.doi.org/10.4161/onci.27185

Ejemplares similares